Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT01107626 2023-07-07

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Phase 3 Completed

1,516 enrolled 12 charts

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02872701 2023-03-24

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Phase 2 Completed

100 enrolled 15 charts

Thoracic

Lung Neoplasms

NCT04241315 2023-03-23

Elucidate

Phase 3 Completed

112 enrolled 15 charts

Thoracic

Lung Neoplasms

NCT05782426 2023-03-23

Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

Phase 2 Unknown

28 enrolled

Thoracic

Non-squamous NSCLC

NCT05631028 2023-03-14

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Phase NA Completed

115 enrolled

Thoracic

Lung Neoplasms

NCT04571632 2022-09-14

Luscid

Phase 2 Unknown

36 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03080311 2022-07-12

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

Phase 1 Completed

50 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT03387332 2021-08-27

APG-1252 in Patients With SCLC or Advanced Solid Tumors

Phase 1 Terminated

24 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT04840290 2021-04-21

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Phase 3 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

SKB500 Combinations in Patients With Small Cell Lung Cancer

DEFLECT I

Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

CYTALUX Dose Extension Study

Phase 3 Clinical Study of AK112 for NSCLC Patients

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases

A Phase II Study of SKB571 in Patients With Lung Cancer

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

MK-2870-003

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

SIM0610-101

Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

KZR-261 in Subjects With Advanced Solid Malignancies

JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer

A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients

A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

AtezoMeso

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

INJECTABL-1

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer

VENEZO-LUNG

ParaSOL

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

KEYNOTE F19

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Elucidate

Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Luscid

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

APG-1252 in Patients With SCLC or Advanced Solid Tumors

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC